Citations
87
17.4 per year
Published
2020
Early treatment of COVID-19 disease: Lessons from the TOGETHER trial
Current Opinion in Pharmacology•2020
Authors
JI Forrest, G Reis, EJ Mills
COVID-19
TOGETHER Trial
Abstract
The COVID-19 pandemic has necessitated rapid development and evaluation of treatments for early symptomatic disease. The TOGETHER trial provides important lessons for early treatment strategies and adaptive trial design in pandemic settings.
Related Publications
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial
The Lancet Global Health • 2022
The Lancet
COVID-19
Effect of early treatment with ivermectin among patients with Covid-19
New England Journal of Medicine • 2022
COVID-19
Ivermectin
A real-time dashboard of clinical trials for COVID-19
The Lancet Digital Health • 2020
The Lancet
COVID-19